Emma Hall is a Reader of Oncology Trials and Deputy Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU). She is a chartered statistician with over 20 years’ experience in the design and analysis of oncology clinical trials. Dr Hall is a member of the National Clinical Research Institute (NCRI)’s Prostate and Bladder Clinical Studies Groups, she co-chairs the NCRI Clinical and Translational Radiotherapy Research Group (CTRad) Workstream3 (Phase 3 Trials and Methodology) and is a member of CTRad’s Executive Committee. She sits on the independent data monitoring and trial steering committees for a number of international and national clinical trials and is a member of the Marie Curie Research Funding Committee. Dr Hall leads the ICR-CTSU’s portfolio of research in urological and head and neck cancers.
The focus of her more recent work involves trials aimed at maximising benefit in the treatment of urological cancers and trials of radiotherapy in head and neck cancer. She collaborates with clinical coordinators and investigators nationally and is a member of the NCRI Bladder and Testis Clinical Studies Groups and its Clinical and Translational Radiotherapy Research Group. She is a member of Cancer Research UK’s Clinical Trials Awards and Advisory Committee and sits on a number of independent data monitoring committees for national Phase II and III trials.